Device
Colovac
Colovac is a medical device with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
terminated133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Safe Anastomosis Feasibility Study
NCT05180565
terminatednot_applicable
SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study
NCT05010850
completednot_applicable
a Study to Investigate the Efficacy, and Safety of the Colovac Colorectal Anastomosis Protection Device.
NCT03352570
Clinical Trials (3)
Showing 3 of 3 trials
NCT05180565Not Applicable
Safe Anastomosis Feasibility Study
NCT05010850Not Applicable
SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study
NCT03352570Not Applicable
a Study to Investigate the Efficacy, and Safety of the Colovac Colorectal Anastomosis Protection Device.
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3